Cite

HARVARD Citation

    Balakumaran, J. et al. (2019). Evaluating the endometabolic and bone health effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia: a systematic review protocol. BMJ open. 9 (9), p. . [Online]. 
  
Back to record